- Home
- COLL vs FWRG Comparison
COLL vs FWRG Comparison
Compare COLL & FWRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COLL
- FWRG
- Stock Information
- Founded
- COLL 2002
- FWRG 1983
- Country
- COLL United States
- FWRG United States
- Employees
- COLL N/A
- FWRG N/A
- Industry
- COLL Biotechnology: Pharmaceutical Preparations
- FWRG Restaurants
- Sector
- COLL Health Care
- FWRG Consumer Discretionary
- Exchange
- COLL Nasdaq
- FWRG Nasdaq
- Market Cap
- COLL 864.7M
- FWRG 975.3M
- IPO Year
- COLL 2015
- FWRG 2021
- Fundamental
- Price
- COLL $30.23
- FWRG $17.25
- Analyst Decision
- COLL Strong Buy
- FWRG Strong Buy
- Analyst Count
- COLL 5
- FWRG 11
- Target Price
- COLL $43.80
- FWRG $21.82
- AVG Volume (30 Days)
- COLL 321.1K
- FWRG 1.3M
- Earning Date
- COLL 05-08-2025
- FWRG 05-06-2025
- Dividend Yield
- COLL N/A
- FWRG N/A
- EPS Growth
- COLL N/A
- FWRG N/A
- EPS
- COLL 1.25
- FWRG 0.17
- Revenue
- COLL $664,283,000.00
- FWRG $1,055,701,000.00
- Revenue This Year
- COLL $20.00
- FWRG $21.27
- Revenue Next Year
- COLL $3.74
- FWRG $16.07
- P/E Ratio
- COLL $24.13
- FWRG $100.48
- Revenue Growth
- COLL 17.17
- FWRG 14.43
- 52 Week Low
- COLL $23.23
- FWRG $12.90
- 52 Week High
- COLL $42.29
- FWRG $22.71
- Technical
- Relative Strength Index (RSI)
- COLL 64.41
- FWRG 47.97
- Support Level
- COLL $28.81
- FWRG $15.51
- Resistance Level
- COLL $30.17
- FWRG $17.67
- Average True Range (ATR)
- COLL 1.02
- FWRG 0.98
- MACD
- COLL 0.37
- FWRG -0.05
- Stochastic Oscillator
- COLL 93.13
- FWRG 70.96
About COLL Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.
About FWRG First Watch Restaurant Group Inc.
First Watch Restaurant Group Inc is a daytime restaurant concept serving made-to-order breakfast, brunch, and lunch using fresh ingredients. It generates revenues from Restaurant sales and Franchise revenues.